DHG Pharmaceutical Joint Stock Company
DHG Pharmaceutical Joint Stock Company, commonly referred to as DHG Pharma, is a leading player in the pharmaceutical industry based in Vietnam. Established in 1976, the company has its headquarters in Can Tho and operates extensively across major regions in Vietnam, focusing on the production and distribution of high-quality pharmaceutical products. Specialising in a diverse range of medications, including prescription drugs, over-the-counter products, and herbal medicines, DHG Pharma is renowned for its commitment to innovation and quality. The company has achieved significant milestones, including numerous awards for excellence in manufacturing and product development, solidifying its position as a trusted name in healthcare. With a robust market presence, DHG Pharma continues to expand its reach, contributing to the health and well-being of communities throughout Vietnam and beyond.
DitchCarbon Score
How does DHG Pharmaceutical Joint Stock Company's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
DHG Pharmaceutical Joint Stock Company's score of 22 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
DHG Pharmaceutical Joint Stock Company's reported carbon emissions
DHG Pharmaceutical Joint Stock Company, headquartered in Vietnam, currently does not have available data on its carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This absence of data suggests that the company may still be in the early stages of formalising its climate commitments or reporting on its emissions. In the pharmaceutical industry, companies are increasingly recognising the importance of addressing climate change and setting measurable targets to reduce their carbon footprint. As such, DHG Pharmaceutical may benefit from developing a comprehensive strategy to monitor and reduce its emissions in alignment with industry standards.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
DHG Pharmaceutical Joint Stock Company is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
